Ulf Boemer
Impact in
-
- Microtubule and mitosis dynamics
-
- Cancer-related Molecular Pathways
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 6
- Kruppel-like factors research 2
- Oncology 5
- CAR-T cell therapy research 3
- Co-authors
- Karl Ziegelbauer (11 shared papers)Dominik Mumberg (10 shared papers)Peter Ellinghaus (3 shared papers)Michael Brands (5 shared papers)Stuart Ince (6 shared papers)Sebastian Bender (1 shared paper)Marcus Koppitz (1 shared paper)Maria Castedo (1 shared paper)
- Journals
- Cancer Research (12 papers)Assay and Drug Development Technologies (1 paper)Journal of Nuclear Medicine (1 paper)European Journal of Cancer (1 paper)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- GermanyUnited StatesSweden
In The Last Decade
Ulf Boemer
20 papers receiving 257 citations
Peers
Comparison fields: 5 of 61
- Cell Biology 61
- Oncology 77
- Molecular Biology 182
- Cancer Research 32
- Pathology and Forensic Medicine 27
Countries citing papers authored by Ulf Boemer
This map shows the geographic impact of Ulf Boemer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulf Boemer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulf Boemer more than expected).
Fields of papers citing papers by Ulf Boemer
This network shows the impact of papers produced by Ulf Boemer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulf Boemer. The network helps show where Ulf Boemer may publish in the future.
Co-authors
The 25 scholars most cited alongside Ulf Boemer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 83 | |
| 2 | 2019 | 72 | |
| 3 | 2008 | 23 | |
| 4 | 2012 | 19 | |
| 5 | 2011 | 16 | |
| 6 | 2014 | 9 | |
| 7 | 2015 | 8 | |
| 8 | 2024 | 7 | |
| 9 | 2022 | 6 | |
| 10 | 2023 | 4 | |
| 11 | 2015 | 3 | |
| 12 | 2016 | 2 | |
| 13 | 2024 | 2 | |
| 14 | 2013 | 2 | |
| 15 | 2023 | 1 | |
| 16 | 2021 | 1 | |
| 17 | 2014 | 1 | |
| 18 | 2018 | 1 | |
| 19 | 2014 | 1 | |
| 20 | 2016 | 1 |
About Ulf Boemer
Ulf Boemer is a scholar working on Molecular Biology, Oncology, Immunology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 262 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (6 papers), CAR-T cell therapy research (3 papers), Cancer Mechanisms and Therapy (3 papers), Advanced Breast Cancer Therapies (3 papers), Kruppel-like factors research (2 papers), Phagocytosis and Immune Regulation (2 papers), Cancer Research and Treatments (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Cell Biology (61 citations), Oncology (77 citations), Molecular Biology (182 citations), Cancer Research (32 citations) and Pathology and Forensic Medicine (27 citations). Ulf Boemer has collaborated with scholars based in Germany, United States and Sweden. Frequent co-authors include Karl Ziegelbauer, Dominik Mumberg, Peter Ellinghaus, Michael Brands, Stuart Ince, Sebastian Bender, Marcus Koppitz, Maria Castedo, Holger Hess‐Stumpp and Charlotte Kopitz. Their work appears in journals such as Cancer Research, Assay and Drug Development Technologies, Journal of Nuclear Medicine, European Journal of Cancer and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.